In recent decades, lung cancer treatment has been transformed—new surgeries, new radiation techniques, and dramatically ...
A study published this week found that Black Medicare beneficiaries with early-stage NSCLC remain significantly less likely than White beneficiaries to receive curative treatment, largely because of ...
Researchers at Moffitt Cancer Center have identified distinct spatial tumor–immune ecosystems that predict whether patients with advanced non–small-cell lung cancer will benefit from immunotherapy.
Experts explain stage IV lung cancer goals, PD‑L1-driven therapy choices, and when to intensify with chemo plus dual ...
ML-016 is comprised of an amino acid polymer conjugated to doxorubicin with a formulation that includes BrYet's proprietary ...
Researchers at Fred Hutch Cancer Center are testing whether a collaborative AI research platform can accelerate the pace of ...
More than 17,000 individuals with cancer died from their malignancy within a year of their diagnosis during the COVID-19 pandemic than expected based on previous trends.An evaluation of 1-year ...
A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.
Nuvation Bio Inc. (NYSE:NUVB) is one of the best low cost stocks to buy under $5. On March 2, Nuvation Bio (NUVB) reported a ...
Learn about the innovative SHIELD blood test by Guardant Health that aims to detect colorectal cancer early, potentially revolutionizing cancer screening methods. Discover its availability, impact, ...